+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 17Years
All Genders
ID07531511

Observational Study on the Natural Course of SLC6A1 Neurodevelopmental Disorder in Children and Adolescents up to 17 Years

Led by UCB Biopharma SRL · Updated on 2026-07-31

60

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective longitudinal natural history study to collect clinical data on SLC6A1 Neurodevelopmental Disorder NDD, which includes epilepsy, global developmental delay, autism spectrum disorder, or intellectual disability. The study aims to understand the natural course of this condition and evaluate certain assessments to help plan future clinical studies involving patients with this disorder. Approximately 60 patients aged up to 17 years will participate, divided into two age groups under 6 years and 6 to 17 years. This noninterventional, multinational study involves an Enrollment and Baseline visit followed by five study visits over a 2-year observational period. Patients will be observed without receiving experimental treatments, and data will be collected longitudinally to characterize disease progression. The study does not include any treatment interventions but focuses on monitoring and assessments. Participants and their caregivers will be involved in baseline and follow-up visits, including completing diaries and adhering to visit schedules. Researchers will monitor seizure frequency by type and seizure-free days, as well as evaluate test completion rates, patient retention, and EEG assessments over the two years. The study is designed to track the natural development of the disorder, with safety and disease progression measures collected throughout the observation period.

CONDITIONS

Brief Title

SLC6A1-NDD Prospective Longitudinal Natural History Study

Research Team

U

UCB Cares

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here